Rodolpho de Campos Braga

Professional with over ten years of experience in predictive modeling, analytics, and data science focused on pharmaceutical innovation and regulatory toxicology. Doctor in Medicinal Chemistry, enthusiastic and passionate about new technologies, worked in developing several R&D projects and technological products in national and international companies. Founder and CTO of InsilicAll, the 1st LATAM Drug Discovery platform integrating AI and computation to accelerate the design of small molecule, protein therapeutics, and evaluate toxicological safety for registering new products. The Brazilian Pharma & Health (BPH) initiative, represented by ABIQUIFI (Brazilian Association of Pharmaceutical Raw-material Industry) and Apex-Brasil, together with Biominas Brasil, carried out the Mapping of national Startups with a focus on specific segments of the health sector considered attractive and relevant to the present. InsilicAll is among the startups called ?hidden champions?, and the purpose of this study is to increase the attraction of investments and the internationalization of Brazilian solutions. Founder and CTO of PreciseDose, a PIPE-FAPESP phase I funded precision medicine and drug dosing deep tech. early career: * Worked as a senior toxicologist and drug discovery specialist at Altox Alternative Toxicology LTDA. Was responsible for the design and implementation of artificial intelligence system for a variety of challenging projects, including the development of the In Silico Toxicology Platform iS-Tox® (http://www.is-tox.com) (2017-2018). * Worked on the Lead Optimization Latin America project (LOLA) by Drugs for Neglected Diseases initiative (DNDi), as a computational chemistry scientist (2017). * Visiting Professor in Medicinal Chemistry at the University of Turin (UniTO) (2015 ? 2016). *I was honored to be awarded the CINF Scholarship for Scientific Excellence of the American Chemical Society (ACS) (2014).